Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center




A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y90 TARE in Patients with Unresectable Hepatocellular Carcinoma

Liver

Liver
II
Goff, Laura
NCT04541173
VICCGI20110


A Phase I/Ib Global, Multicenter, Open Label Umbrella Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC)

Multiple Cancer Types

Colon, Phase I, Rectal
I
Ciombor, Kristen
NCT04929223
VICCGIP2158

A Phase Ib Open Label Study to assess the Safety and Pharmacokinetics of NUC-3373, a Nucleotide Analogue, given in Combination with Standard Agents used in Colorectal Cancer Treatment

Multiple Cancer Types

Colon, Phase I, Rectal
I
Ciombor, Kristen
NCT03428958
VICCGIP1851

A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma

Sarcoma

Sarcoma
II
Davis, Elizabeth
NCT03141684
VICCSAR16155ET-CT

To learn more about any of our clinical
trials, call 615-936-8422.